These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32589979)

  • 1. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA; Makalo L; Sallah A; Saine H; Joof S; Conteh A; Bah R; Camara Jammeh AF; Bass M; Jallow M; Nnodu OE
    Hemoglobin; 2024 May; 48(3):169-174. PubMed ID: 38980121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
    Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
    PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
    Mukherjee MB; Colah RB; Mehta PR; Shinde N; Jain D; Desai S; Dave K; Italia Y; Raicha B; Serrao E
    Am J Clin Pathol; 2020 Jan; 153(1):82-87. PubMed ID: 31433854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.
    Okeke CO; Chianumba RI; Isa H; Asala S; Nnodu OE
    Front Genet; 2022; 13():1013858. PubMed ID: 36386848
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM; Kuona P; Misihairabgwi JM
    BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for sickle cell disease in a Nigerian hospital.
    Odunvbun ME; Okolo AA; Rahimy CM
    Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal screening of sickle cell anemia: a preliminary report.
    Panigrahi S; Patra PK; Khodiar PK
    Indian J Pediatr; 2012 Jun; 79(6):747-50. PubMed ID: 22278214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a novel point of care testing device for sickle cell disease.
    Kanter J; Telen MJ; Hoppe C; Roberts CL; Kim JS; Yang X
    BMC Med; 2015 Sep; 13():225. PubMed ID: 26377572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update.
    Kasai ET; Gulbis B; Ntukamunda JK; Bours V; Batina Agasa S; Marini Djang'eing'a R; Boemer F; Katenga Bosunga G; Ngbonda Dauly N; Sokoni Vutseme J; Boso Mokili B; Alworong'a Opara JP
    Hematology; 2023 Dec; 28(1):2213043. PubMed ID: 37183964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R; Pascaud O; Bévier A; Finet C; Benkerrou M; Elion J
    J Med Screen; 2001; 8(1):8-14. PubMed ID: 11373853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.